Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) announced today that its Chief Executive Officer, Dr. Daniel Teper, has established a stock trading ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE